Exclusive: Google unveils vetting process for drug rehab ads

SAN FRANCISCO (Reuters) – Google told Reuters Monday it would resume accepting ads from U.S. addiction treatment centers in July, nearly a year after the Alphabet Inc unit suspended the lucrative category of advertisers for numerous deceptive and misleading ads.


Source: Reuters Medical News

Survival data boosts Merck's Keytruda lead in lung cancer

(Reuters) – Merck & Co’s immunotherapy Keytruda plus chemotherapy significantly improved overall survival in newly-diagnosed patients with advanced non-small cell lung cancer in a closely-watched study, cementing its lead position over Bristol-Myers Squibb Co and others in the most lucrative oncology market.


Source: Reuters Medical News

J&J Baby Powder litigation takes new focus with asbestos claims

NEW YORK (Reuters) – A $117 million verdict against Johnson & Johnson and a supplier in favor of a man who said his asbestos-related cancer was caused by long-term use of J&J’s Baby Powder could open a new front for thousands of cases claiming the widely-used product caused cancer, legal experts and plaintiffs lawyers said.


Source: Reuters Medical News

Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) – Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product.


Source: Reuters Medical News